Martine A. Rothblatt, Chairperson & CEO at UNITED THERAPEUTICS Corp (UTHR), sold 9,500 shares at $525.50 ($5.1M) on 2026-10-08, disclosed to the SEC on 2026-10-09.
Scheduled sale ($5.1M) by Chairperson & CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $525.50 | 200 | $105K | 2.1% |
| 2 | $526.66 | 767 | $404K | 8.0% |
| 3 | $527.57 | 273 | $144K | 2.8% |
| 4 | $528.63 | 200 | $106K | 2.1% |
| 5 | $530.13 | 199 | $105K | 2.1% |
| 6 | $531.07 | 1,061 |
| $563K |
| 11.1% |
| 7 | $532.07 | 600 | $319K | 6.3% |
| 8 | $533.36 | 800 | $427K | 8.4% |
| 9 | $534.28 | 920 | $492K | 9.7% |
| 10 | $535.46 | 480 | $257K | 5.1% |
| 11 | $536.61 | 824 | $442K | 8.7% |
| 12 | $537.53 | 1,016 | $546K | 10.8% |
| 13 | $538.60 | 605 | $326K | 6.4% |
| 14 | $539.58 | 1,091 | $589K | 11.6% |
| 15 | $540.51 | 424 | $229K | 4.5% |
| 16 | $541.23 | 40 | $22K | 0.4% |
| Total | $534.31 avg | 9,500 | $5.1M | 100% |
| Filing → |
| UTHR | SELL | 2026-10-14 | $5.2M | — | Filing → |
| UTHR | SELL | 2026-10-13 | $5.2M | — | Filing → |
| UTHR | SELL | 2026-10-13 | $5.2M | — | Filing → |